U.S. Spinal Surgery Market Growth Fueled by MI Technology

Spinal surgery has evolved significantly from its early days. Advancements in technology and approaches (anterior, lateral, posterior) has helped boost the procedure’s efficacy for both physicians and patients.

The development of advanced surgical systems, demand for more minimally invasive techniques, and an aging population is driving the spinal surgery market’s growth in the United States, according to GlobalData. Technological advancements from both major industry leaders and innovative smaller companies are changing the landscape of U.S. spinal surgery. 
 
According to GlobalData forecasts, the U.S. spinal surgery market is expected to grow 2% annually through 2033, with minimally invasive spinal devices forecast to expand 5% per year.
 
In August, Johnson & Johnson MedTech introduced a dual-use robotics and standalone navigation platform in the United States for use with its VELYS robot in spine surgeries. The system is designed for planning and performing spinal fusion procedures, specifically involving cervical, thoracolumbar, and sacroiliac spine surgeries. The aim of the technology is to provide surgeons with flexibility in their approach and planning. The active robotics component offers surgical guidance customized to the surgeon’s preferences. 
 
In July, eCential Robotics received U.S. Food and Drug Administration 501(k) clearance for its spine navigation and robotic-assistance device, which was developed in collaboration with Johnson & Johnson MedTech. 
 
“Medtronic, a dominant force in the spinal surgery market, continues to demonstrate strong growth driven by innovation,” GlobalData Medical Analyst Thomas Fleming commented. “Earlier this year, the company announced the launch of the UNiD ePRO service in the U.S. This service integrates with existing electronic medical records (EMR), with the aim of simplifying the collection of patient-reported outcomes. The service’s goal is to increase the standard of care by enhancing recovery.”
 
In addition to the major players in the market, there are a diverse set of companies showing promise with new technology. In August, Spineology, which focuses on minimally invasive spinal surgeries, secured $25 million in Series AA financing to help deploy its OptiMesh technology in the United States. The OptiMesh implant is placed through a small lumbar interbody fusion tubular retractor and expands to be endplate-conforming. Currently, 400,000 lumbar interbody fusion operations are done annually in the United States.
 
“Looking ahead, the U.S. spinal surgery market is expected to continue growing, propelled by an aging population and increasing rates of degenerative disc diseases, spinal stenosis, and other spinal conditions,” Fleming said. “The demand for innovative, less-invasive surgical solutions will remain a key driver of market expansion in the coming years.”